Skip to main content

NANO THERAPY FOR DIABETICS

In a good news for diabetes patients, researchers have developed a smart network of nano-particles that can be injected into the body to release insulin when blood-sugar levels rise. The technique was able to maintain normal blood sugar levels for more than a week in animal-based laboratory tests. "We've created a 'smart' system that is injected into the body and responds to changes in blood sugar by releasing insulin, effectively controlling blood-sugar levels," said Dr Zhen Gu, lead author of the paper. "We've tested the technology in mice, and one injection was able to maintain blood sugar levels in the normal range for up to 10 days," Gu said. Currently, diabetes patients must take frequent blood samples to monitor their blood-sugar levels and inject insulin as needed to ensure their blood sugar levels are in the "normal" range. However, these injections can be painful, and it can be difficult to determine the accurate dose level of insulin. Administering too much or too little insulin poses its own health risks. The new, injectable nano-network developed by researchers at North Carolina State University, the University of North Carolina at Chapel Hill, the Massachusetts Institute of Technology and Children's Hospital Boston is composed of a mixture containing nanoparticles with a solid core of insulin, modified dextran and glucose oxidase enzymes. When the enzymes are exposed to high glucose levels they effectively convert glucose into gluconic acid, which breaks down the modified dextran and releases the insulin. The insulin then brings the glucose levels under control. The gluconic acid and dextran are fully biocompatible and dissolve in the body. Each of these nanoparticle cores is given either a positively charged or negatively charged biocompatible coating. The positively charged coatings are made of chitosan, a material normally found in shrimp shells, while the negatively charged coatings are made of alginate, a material normally found in seaweed. When the solution of coated nanoparticles is mixed together, the positively and negatively charged coatings are attracted to each other to form a "nano-network." Once injected into the subcutaneous layer of the skin, the nano-network holds the nanoparticles together and prevents them from dispersing throughout the body.

Comments

Popular posts from this blog

WORLD'S OLDEST WOMAN

Misao Okawa celebrates her 115th birthday in Osaka, western Japan on March 5, 2013. Okawa was formally recognized as the world's oldest woman.

B cell- RESPOSE KEY TO FIGHT DIABETES & GUM DESEASE

Modulation of one of the most important blood cells involved in the human immune response may effectively treat and prevent the symptoms of type 2 diabetes and periodontitis simultaneously, scientists say. Researchers have found that B cells, blood cells involved in the human immune response, promote inflammation and bone loss in type 2 diabetes-associated periodontal disease. These findings support the idea that treatments that manipulate the responses of B cells may treat or prevent this complication. "Our study identified common inflammatory mechanisms shared by type 2 diabetes and periodontal disease. It paves the way for the development of novel therapeutics which aim to simultaneously treat both type 2 diabetes and its complications," said Min Zhu, a researcher involved in the work from the department of microbiology at Boston University School of Medicine in Boston, Massachusetts. To make this discovery, scientists used an experimental model (mouse model) of periodo...

ANIL AND FAMILY

Chairman Reliance, ADAG, Anil Ambani's family members (left to right) mother Kokilaben, wife Tina and son Anshul.